Alberta Hsueh Min Yen, MD
Cardiovascular Disease (Cardiology) · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Hospitals listed: Kaiser Foundation Hospital-Santa Clara. That is not proof they admit you there this week.
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Yen’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A126540 · Current
Licensed to practise in California · since 2013 · expires 2027-02-28 · University of Michigan Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Kaiser Foundation Hospital-Santa ClaraSanta Clara, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Kaiser Permanente, which runs 41 hospitals in 3 statesPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.38, Oct 2024 – Sep 2025
See every measure and the patient survey for Kaiser Foundation Hospital-Santa Clara
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Safety: 2 better, 4 the same, 0 worse of 6 measures. Readmissions: 0 better, 1 the same, 1 worse of 2 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.38 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0 to 2.09) · 181 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.61 to 1.42) | No different | Jul 2022 – Jun 2024 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 312 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 3,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 910 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 1,036 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.53 (2.03 to 7.03) · 235 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.57 (0 to 3.25) · 83 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.5 (0.82 to 4.18) · 178 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.73 (3.81 to 19.64) · 74 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.31 (1.3 to 9.32) · 94 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.28) · 37 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.34 (0 to 1.34) · 819 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.72 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.049 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.598 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.926 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13 · 589 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.7 · 828 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 107.6 · 27 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 642 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 7.8 · 249 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 181 cases | None | Jul 2023 – Jun 2025 |
What patients said (572 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$1,436
Medicare paid this office $1,436 for 17 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
17 Original Medicare patients in 2024. Average age 75 · Health risk score 1.78. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 71% · Coronary heart disease 65%.
The office billed $6,256, Medicare allowed $1,889 and paid $1,436; for 19 services of 9 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 17 | 19 | 75 | 1.78 | $6,256 | $1,436 |
| 2023 | 44 | 71 | 70 | 2.38 | $10,706 | $2,062 |
| 2022 | 20 | 28 | 66 | 3.90 | $3,514 | $721 |
| 2021 | 45 | 69 | 72 | 2.96 | $7,903 | $1,521 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 24 | $190 | $6 |
2022: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 12 | $97 | $7 |
2021: 1 service
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 32 | $351 | $7 |
Medicaid work
$327 in 2024
Medicaid paid $327 for 29 billed services this clinician did in 2024, up to 17 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 29 | $327 |
| 2024 | 29 | 1 | 17 | $327 |
| 2023 | 138 | 1 | 36 | $149 |
| 2022 | 72 | 1 | 31 | $148 |
| 2021 | 234 | 1 | 30 | $520 |
| 2020 | 153 | 1 | 29 | $194 |
| 2019 | 17 | 1 | 16 | $16 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 138 | $149 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 72 | $148 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 234 | $520 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 153 | $194 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 17 | $16 |
Drugs they prescribed that Part D paid
$136,786
Pharmacies billed $136,786 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 866) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
704 generic and 162 brand-name prescriptions · $136,786 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Entresto | 48 | $55,827 | $1,163 |
| Jardiance | 80 | $40,559 | $507 |
| Pradaxa | 13 | $3,905 | $300 |
| Amiodarone | 90 | $2,543 | $28 |
| Metoprolol | 109 | $1,372 | $13 |
See all 18 drugs
| Entresto | 48 | $55,827 | $1,163 |
| Jardiance | 80 | $40,559 | $507 |
| Pradaxa | 13 | $3,905 | $300 |
| Amiodarone | 90 | $2,543 | $28 |
| Metoprolol | 109 | $1,372 | $13 |
| Flecainide Acetate | 34 | $1,348 | $40 |
| Spironolactone | 106 | $1,186 | $11 |
| Sotalol | 39 | $1,041 | $27 |
| Atorvastatin | 61 | $770 | $13 |
| Furosemide | 41 | $563 | $14 |
| Isosorbide Mononitrate Er | 34 | $483 | $14 |
| Losartan | 32 | $353 | $11 |
| Clopidogrel | 18 | $345 | $19 |
| Lisinopril | 22 | $317 | $14 |
| Torsemide | 13 | $282 | $22 |
| Metoprolol | 22 | $258 | $12 |
| Carvedilol | 21 | $252 | $12 |
| Rosuvastatin | 15 | $175 | $12 |
Year by year
| 2024 | 866 | 220 | 0% (0) | 19% | $136,786 |
| 2023 | 970 | 276 | 0% (0) | 20% | $143,760 |
| 2022 | 596 | 172 | 0% (0) | 22% | $63,809 |
| 2021 | 451 | 118 | 0% (0) | 25% | $57,834 |
| 2020 | 260 | 67 | 0% (0) | 20% | $24,204 |
| 2019 | 25 | 12 | 0% (0) | None | $5,194 |
| 2015 | 11 | None | None | 0% | $285 |
| 2014 | 39 | 11 | 33% (13) | None | $1,150 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 18 drugs
| Jardiance | 94 | $59,468 | $633 |
| Entresto | 31 | $30,634 | $988 |
| Pradaxa | 15 | $4,562 | $304 |
| Amiodarone | 77 | $2,131 | $28 |
| Metoprolol | 119 | $2,053 | $17 |
| Flecainide Acetate | 26 | $1,256 | $48 |
| Atorvastatin | 81 | $1,214 | $15 |
| Spironolactone | 105 | $1,160 | $11 |
| Sotalol | 39 | $976 | $25 |
| Furosemide | 54 | $768 | $14 |
| Isosorbide Mononitrate Er | 46 | $620 | $13 |
| Metoprolol | 47 | $611 | $13 |
| Carvedilol | 33 | $408 | $12 |
| Losartan | 32 | $347 | $11 |
| Clopidogrel | 17 | $326 | $19 |
| Rosuvastatin | 22 | $268 | $12 |
| Lisinopril | 20 | $240 | $12 |
| Nitroglycerin | 16 | $223 | $14 |
2022: 15 drugs
| Jardiance | 39 | $23,911 | $613 |
| Pradaxa | 14 | $5,852 | $418 |
| Amiodarone | 46 | $1,428 | $31 |
| Metoprolol | 78 | $1,253 | $16 |
| Flecainide Acetate | 24 | $1,212 | $51 |
| Atorvastatin | 57 | $948 | $17 |
| Furosemide | 44 | $790 | $18 |
| Sotalol | 22 | $676 | $31 |
| Carvedilol | 40 | $486 | $12 |
| Lisinopril | 30 | $377 | $13 |
| Spironolactone | 34 | $367 | $11 |
| Isosorbide Mononitrate Er | 23 | $308 | $13 |
| Losartan | 28 | $300 | $11 |
| Clopidogrel | 14 | $260 | $19 |
| Metoprolol | 18 | $208 | $12 |
2021: 14 drugs
| Jardiance | 31 | $14,144 | $456 |
| Pradaxa | 16 | $11,772 | $736 |
| Entresto | 14 | $8,462 | $604 |
| Amiodarone | 42 | $1,274 | $30 |
| Metoprolol | 55 | $988 | $18 |
| Flecainide Acetate | 18 | $901 | $50 |
| Atorvastatin | 38 | $617 | $16 |
| Furosemide | 31 | $548 | $18 |
| Spironolactone | 32 | $372 | $12 |
| Lisinopril | 24 | $280 | $12 |
| Carvedilol | 26 | $277 | $11 |
| Losartan | 23 | $267 | $12 |
| Metoprolol | 19 | $218 | $11 |
| Isosorbide Mononitrate Er | 14 | $202 | $14 |
2020: 9 drugs
| Pradaxa | 15 | $9,856 | $657 |
| Atorvastatin | 29 | $508 | $18 |
| Metoprolol | 24 | $472 | $20 |
| Lisinopril | 27 | $297 | $11 |
| Furosemide | 16 | $283 | $18 |
| Spironolactone | 16 | $208 | $13 |
| Losartan | 16 | $200 | $13 |
| Isosorbide Mononitrate Er | 15 | $190 | $13 |
| Metoprolol | 14 | $153 | $11 |
Money from drug and device companies
$16 in 2021
A payment is not proof that care is biased.
| Boston Scientific | Watchman | $16 | 1 payment
|
See the published payment
| Boston Scientific | Meals · 2021-04-08 | Watchman | $16 |
Professional record
- NPI
- 1962778258
- Licence
- CA A126540California A126540: Current · expires 2027-02-28
- Trained
- University of Michigan Medical School, 2012
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X); Student in a training program (390200000X)
- Mailing address
- 710 Lawrence Expy, Santa Clara, CA, 95051
- NPI first listed
- 2012-03-30
- NPI last updated
- 2021-12-17
- NPI record certified
- 2020-12-21
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305
This office lists an electronic records connection.